Barclays PLC, Geode Capital Management LLC, National Bank of Canada FI, Y Intercept Hong Kong Ltd, State Street Corp, and The Manufacturers Life Insurance Company have reportedly increased their stakes in the bio-tech company
Zebra Technologies. The company's stock, reported under NASDAQ:ZBRA, has been on a consistent uptrend, indicating possible driving fundamentals. Meanwhile, Orion Portfolio Solutions LLC, Quadrature Capital Ltd, Stifel Financial Corp, and Point72 Asset Management L.P. have reportedly sold shares of the company. However, Zebra remains a top growth investor stock according to
Goldman Sachs and has passed its Q3 goals. Concerning earnings, Zebra Technologies has also outperformed and beat Q2 and Q3 earnings estimates. The company also surpassed its sales growth targets and is seen innovating with AI-driven solutions for frontline workers. For long-term investors, it's reported that an investment into Zebra Technologies a year ago could have delivered an 83% gain. However, the company's Chief Accounting Officer and Chief Strategy Officer traded the company's stock, which could be an indicator of the company's financial strategy.
Zebra Technologies Stocks ZBRA News Analytics from Tue, 30 Jul 2024 07:00:00 GMT to Fri, 13 Dec 2024 11:02:09 GMT -
Rating 8
- Innovation 8
- Rumor -2
